v3.25.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities    
Net loss from continuing operations $ (12,269) $ (14,851)
Adjustments to reconcile net loss to net cash provided by operating activities    
Accretion expense 1,906 5,875
Depreciation of property and equipment and amortization of intangible assets 4,710 5,000
Amortization of operating right-of-use assets 772 716
Share-based compensation 1,514 1,485
Deferred income tax expense 457 (256)
(Gain) loss on fair value of derivative liabilities and purchase option derivative assets (97) 983
Unrealized and realized loss on investments 742  
Loss from revaluation of contingent consideration 381 1,393
Impairment of property and equipment and right of use assets   2,438
Derecognition of ROU asset (5)  
Provision for expected credit losses 479 67
Unrealized and realized foreign exchange loss (gain) 42 285
Changes in operating assets and liabilities    
Receivables 1,637 1,954
Inventory 1,853 2,476
Accounts payable and accrued liabilities and other payables (2,264) (3,511)
Income taxes paid and tax related liabilities 7,725 8,871
Prepaid expense and other current assets 839 1,189
Other assets and liabilities (418) (863)
Net cash provided by operating activities 8,004 13,251
Investing activities    
Investment in property and equipment (2,458) (2,796)
Interest received on investment in note receivable 61  
Investment in intangible assets (659) (127)
Payment for land contracts (228) (250)
Cash portion of consideration paid in acquisitions, net of cash of acquired   (250)
Net cash used in investing activities (3,284) (3,423)
Financing activities    
Proceeds from loan payable, net of transaction costs   3,137
Loan principal paid (980) (12,215)
Capital distributions paid to non-controlling interests (738) (337)
Payment for contingent consideration (386)  
Payments made for financing obligations and finance lease   (184)
Repurchases of common shares (231)  
Net cash used in financing activities (2,335) (9,599)
Net increase in cash and cash equivalents and restricted cash during the period 2,385 229
Net effects of foreign exchange (14) 198
Cash and cash equivalents and restricted cash, beginning of the period 26,987 25,347
Cash and cash equivalents and restricted cash, end of the period 29,358 25,774
Supplemental disclosure with respect to cash flows    
Cash received for income tax, net 3,282 1,013
Interest paid 6,420 6,264
Lease termination fee paid   163
Non-cash transactions    
Equity and warrant liability issued for acquisitions and non-controlling interest   4,674
Change in accrued capital expenditures $ 191 $ 1,253

Source

10-Q PDF
XBRL